Botox and Multiple sclerosis - a phase IV clinical study of FDA data
Summary:
Multiple sclerosis is reported as a side effect among people who take Botox (botulinum toxin type a), especially for people who are female, 50-59 old, have been taking the drug for < 1 month also take Ocrevus, and have Relapsing-remitting multiple sclerosis.
The phase IV clinical study analyzes which people have Multiple sclerosis when taking Botox. It is created by eHealthMe based on reports of 69,984 people who have side effects when taking Botox from the FDA, and is updated regularly.
What is Botox?
Botox has active ingredients of botulinum toxin type a. It is often used in migraine. eHealthMe is studying from 70,512 Botox users. Check the latest studies of Botox.
What is Multiple sclerosis?
Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath) is found to be associated with 1,106 drugs and 1,356 conditions by eHealthMe. Check the latest studies of Multiple sclerosis.
69,984 people reported to have side effects when taking Botox.
Among them, 235 people (0.34%) have Multiple sclerosis.
Among these 235 people:
How long have people been on Botox when they have Multiple sclerosis? *
What is the gender of people who have Multiple sclerosis when taking Botox? *
What is the age of people who have Multiple sclerosis when taking Botox? *
What are other drugs people take besides Botox? *
What are other side effects people have besides Multiple sclerosis? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Botox and have Multiple sclerosis?
- Check whether Multiple sclerosis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Botox:
- Botox (70,512 reports)
Multiple sclerosis treatments and more:
- Multiple sclerosis (799,632 reports)
How severe was Multiple sclerosis and when was it recovered:
Expand to all the drugs that have ingredients of botulinum toxin type a:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Botox:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Multiple sclerosis:
- Multiple sclerosis (1,106 drugs)
Browse all the conditions that are associated with Multiple sclerosis:
- Multiple sclerosis (1,356 conditions)
Related publications that referenced our studies
- Christopher KL, Elner VM, Demirci H, "Conjunctival Lymphoma in a Patient on Fingolimod for Relapsing-Remitting Multiple Sclerosis", Ophthalmic Plastic & Reconstructive Surgery, 2017 May .
- Christopher, K. L., Elner, V. M., & Demirci, H. , "Conjunctival lymphoma in a patient on fingolimod for relapsing-remitting multiple sclerosis", Ophthalmic plastic and reconstructive surgery , 2014 Jan .
- Christopher KL, Elner VM, Demirci H, "Conjunctival Lymphoma in a Patient on Fingolimod for Relapsing-Remitting Multiple Sclerosis", Ophthalmic Plastic & Reconstructive Surgery, 2017 May .
- Christopher, K. L., Elner, V. M., & Demirci, H. , "Conjunctival lymphoma in a patient on fingolimod for relapsing-remitting multiple sclerosis", Ophthalmic plastic and reconstructive surgery , 2014 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on botulinum toxin type a (the active ingredients of Botox) and Botox (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Wellbutrin vs. Depakote Er, side effect and effectiveness comparison - 10 seconds ago
- Drug interactions of Viagra and Vitamin B12 - 25 seconds ago
- Could Tapentadol cause Muscle Twitching? - 46 seconds ago
- Could Versed cause Injection Site Oedema? - 47 seconds ago
- Could Profen cause Hypophagia? - 58 seconds ago
- Drug interactions of Linezolid and Kenalog - a minute ago
- Drug interactions of Tranxene and Lescol - a minute ago
- Tylenol vs. Prialt, side effect and effectiveness comparison - a minute ago
- Drug interactions of Cefazolin and Kaletra - a minute ago
- Could Chlorpheniramine Maleate cause Hypophosphataemia? - a minute ago